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Keratinocyte expression of class II antigens (HLA-DR, 
human; la, murine) is associated with certain cutaneous dis-
eases, especially those marked by the infiltration of immune 
and inflammatory cells into the skin. It has been shown that 
interferon-gamma (IFN -gamma) is capable of inducing 
human keratinocytes to express HLA-DR. Similar results, 
however, have not been duplicated in murine systems. The 
purpose of this study was to determine whether IFN-gamma 
was capable of inducing murine keratinocyte expression ofIa 
in vivo in an experimental model in which epithelial cells in a 
variety of organs were shown to express la after the i.v. 
injection ofIFN -gamma. Recombinant murine IFN-gamma 
was injected into BALB I c mice. Biopsies of skin and intestine 
were ana lyzed by indirect immunoperoxidase to identify la-
expressing keratinocytes and mucosal cells, respectively. In-
terferon-gamma was administered as either: 1) a single s.c. 
T he pathogenesis of many cutaneous diseases involves the infi ltration of immune and inflammatory cells into the skin. The level of cellular infiltrate and sever-ity of these conditions are frequently paral leled by the induced expression of HLA-DR antigens (class II 
molecu les encoded for by genes within the major histocompatibility 
complex) by the keratinocytes [1-4]. Because class II molecules 
play an important role in antigen presentation and the various cellu-
lar interactions required for an immune response [5], it is conceiv-
able that HLA-DR+ keratinocytes influence certain skin-associated 
immune reactions and disease processes. 
It has been shown that human keratinocytes, cultured in vitro, are 
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injection, 2) multiple i.v. injections of increasing doses (103-
105 U Id) on 3 consecutive d, or 3) i.p. injections of 5 X 
104 U/d or 5 X 105 U/d on 6 consecutive d. At all i.v. and 
i.p. injection doses, the intestinal villi mucosal cells were 
induced to express la. Keratinocyte expression of la, how-
ever, was observed only in animals that received the two 
higher i.p. doses. Procedures to augment Ia expression, e.g., 
combined treatment with pertussis toxin, dinitrofluoroben-
zene, tumor necrosis factor, and indomethacin, did not en-
hance the ability of IFN-gamma to induce keratinocyte ex-
pression of la. We conclude that: 1) high doses of 
IFN-gamma are required to induce murine keratinocyte Ia 
expression in vivo and 2) low doses ofIFN-gamma. although 
capable of inducing intestinal mucosal cells to express la, do 
not induce keratinocyte la expression. J Invest Dermatol 
93:33-39, 1989 
readily induced to express HLA-DR antigens when treated with 
low doses of the T-cell lymphokine gamma-interferon (IFN-
gamma) [6]. This suggests that the release of IFN-gamma by acti-
vated T-cells that infiltrate the skin causes the keratinocytes in the 
overlying epidermis to express HLA-DR antigens. Under certain 
experimental conditions, murine keratinocytes can be induced in 
vivo to express la (the murine equivalent ofHLA-D antigens) [7,8]. 
Curiously, the keratinocytes of athymic nude mice are easily in-
duced to express 1a in vivo despite the absence ofIFN-gamma-pro-
ducing T -cells in these animals [9]. Unlike human keratinocytes [6], 
cultured murine keratinocytes are not readily induced to express 
class II antigens when treated with IFN-gamma in vitro, although 
the cells are stimulated to express higher amounts of class I antigens 
(personal observations). We have thus concluded that: 1) there is a 
differential sensitivity of murine and human keratinocytes to the 
induced expression of class II antigens in response to IFN-gamma 
and 2) agents other than IFN-gamma may stimulate murine kera-
tinocytes to express la. 
Momburg et al [10] reported that various parenchymal (e.g., in-
testinal mucosa) and lymphoid cells are induced to express invariant 
chain and Ia antigens when mice are treated with exogenous recom-
binant murine IFN-gamma. Although a number of different organs 
were examined in this study, there was no indication as to the effect 
of IFN-gamma treatment on la expression by cells within the epi-
dermis [10]. The purpose of the present study was to use a similar 
dose/response protocol to determirie the amount of IFN-gamma 
required to induce both intestinal mucosal cells and keratinocytes to 
express la. Our results indicate that these two epithelial cell popula-
tions possess distinct susceptibilities to the la-inducing properties of 
IFN-gamma. 
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MATERIALS AND METHODS 
Experimental Animals Nude heterozygous mice on the BALB/ 
c (H-2d) background were raised in our breeding colony at the 
University of Utah with stock obtained from the Animal Produc-
tion Facility at the National Institutes of Health. All mice were 
housed at a maximum density of six animals per 18 X 25-cm cage 
and maintained on Wayne sterilizable lab bloc and acidified water 
ad libitum. Animals were sex-matched and were between 8 and 
12 wk old at the onset of a given experiment. Animal care was 
supervised by the University of Utah Vivarium director, in accord-
ance with prescribed NIH guidelines (NIH publication #85-23). 
All experiments described in this study were approved by the Insti-
tutional Animal Care and Use Committee. 
In Vivo Administration of Gamma Interferon Recombinant 
murine IFN-gamma, produced by Genentech, Inc., San Francisco, 
CA, was supplied by Dr. Michael Shepard. The IFN-gamma was 
diluted to the appropriate concentrations in phosphate-buffered sa-
line (PBS). Groups of mice with an average body weight of 20 g 
were administered IFN -gamma by one of the following methods: 1) 
a single subcutaneous injection (105 U /50,u1 PBS) in the right ear 
pinna; 2) multiple i.v. injections on 3 consecutive d (1st d, 
103 U/I00,u1 PBS: 2nd d, 10· U/I00,ul PBS; 3rd d, 105 U/I00,ul 
PBS), 3) i.p. injections of 5 X 10· U/I00,ul PBS/d on 6 consecu-
tive d, or 4) i.p. injections of5 X 105 U/I00,ul PBS/d on 6 consec-
utive d. Control animals received equal volumes of PBS adminis-
tered by the same protocols. Biopsies of ear skin and small intestine 
were taken 24 h after the last treatment from animals killed by CO2 
euthanasia. 
Combined Treatments Pertussis toxin (PT) was purchased from 
List Biological Laboratoty (Monterey, CA) and diluted in PBS to a 
concentration of 200 ng/l00,u1 immediately before use. Animals 
received an i.v. injection of200 ng ofPT 24 h before IFN-gamma 
treatment. Indomethacin-containing pellets were obtained from 
Innovative Research of America (Rockville, MD). An indometha-
cin pellet calculated to release the incorporated drug at a constant 
rate (1.25 ,ug/d) over 20-d was implanted subcutaneously by trocar 
5 d before initiation of IFN-gamma treatments. Dinitrofluoroben-
zene (DNFB) was purchased from Sigma Chemical Co. (St. Louis, 
MO) and diluted to 0.5% in a solution of acetone/olive oil (4:1). A 
single topical application of 10 ,ul of 0.5% DNFB was made to the 
right ear pinna of each test animal. The IFN-gamma treatment was 
administered either 3 d before or 3 dafter DNFB application. Ear 
thickness was measured 24 h after the last manipulation (DNFB 
application or IFN-gamma treatment) and skin biopsies were taken 
for analysis of Ia expression by epidermal cells. Ear swelling was 
measured with an engineer's micrometer and the difference in ear 
thickness of a constant area of the challenged ear pinna compared 
with that of the unchallenged ear was used to calculate the mean 
units of ear swelling for each group [11] . Tumor necrosis factor 
(TNF), supplied by Dr. Michael Shepard (Genentech, Inc., San 
Francisco, CA), was diluted to a concentration ofl03 U /100,u1 PBS 
immediately before use. The TNF was given concomitantly with 
IFN-gamma intravenously as 103 U/d on 3 consecutive d. For all 
combined treatments, IFN-gamma was given intravenously as in-
creasing doses (103- 105 U/d) on 3 consecutive d or 5 X 10· intra-
peritoneally on each of 6 consecutive d. 
Histochemical Staining of Epidermal Sheets Pieces of ear 
skin were mechanically separated and incubated, dermal side down, 
in an isotonic 26 mM EDT A/PBS sol ution [12). After 2 h at 37 0 C, 
the epidermis was separated as an intact sheet from the underlying 
dermis with a fine forceps and cut into 4 X 4-mm pieces. The epi-
dermal pieces were histochemically stained for the identification of 
ATPase and la-expressing epidermal cells. 
The McKenzie and Squier method [13], with minor modifica-
tion, was used to identify cells possessing ATPase activity. Briefly, 
the epidermal sheets were washed in cold 0.2 M Trismal buffer, pH 
7.3 for a total of 20 min. They were then incubated at 37"C for 
20 min in a substrate consisting of 10 mg ATP (Sigma Chemical 
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Co., St. Louis, MO), 5 ml 5% MgSO., 3 m12% PBN03 in 42 rnl 
Trismal buffer. After a thorough wash in Trismal buffer, the sheets 
were treated with a 5% ammonium sulfide solution for 5 min. 
To identify la-expressing cells, we fixed the epidermal pieces in 
acetone, rehydrated with PBS, and incubated in either tissue culture 
medium (control) or I-A and I-E-specific monoclonal antibody con-
taining hybridoma tissue culture supernatants. The monoclonal an-
tibodies (obtained from the American Type Culture Collection, 
Rockville, MD) used in this study included: 14-4-4S, specific for the 
la' determinant associated with I-E antigens [14], and MK.D6, spe-
cific for an I-Ad determinant [IS). Monoclonal antibody 10-3.6.2, 
specific for l-Ak, was used as an IgG isotype staining control, as it 
does not react with the lad haplotype of the BALB / c nude heterozy-
gous mice. Tissue-bound antibody was assessed by an indirect im-
munoperoxidase staining procedure using Vectastain reagents (Vec-
tor Laboratories, Burlingame, CA) with 3-amino-9-ethylcarbazole 
as the developing substrate. 
Stained epidermal sheets were mounted flat on slides in glycerol 
and were examined by light microscopy. The number of ATPase 
and la+ epidermal cells was determined by randomly counting 10 
fields at X400 with an ocular grid of known area. From these values 
the mean number of positive epidermal cells/mm2 was calculated 
[13]. The reported density of ATPase/la+ positive dendritic epider-
mal cells (DEC) represents the combined mean ± SEM of the ten 
samplings from all the pieces analyzed within a particular treatment 
group. 
Immunofluorescent Staining of Intestinal Mucosal Cells 
The following procedure was used to identify la-expressing gut 
epithelial cells. Pieces of the small intestine, taken from the midi!-
eum, were embedded in OCT compound embedding media (Tissue 
TEK, Miles Scientific Inc., Naperville, IL) and frozen by dropping 
the samples into liquid nitrogen. Embedded samples were cut at 
5-,um thickness with a Cryocut (International Equipment Co., 
Needham Heights, MA) and were placed on gelatin-coated slides. 
After drying the slides for 30 min at room temperature, we rehy-
drated cut sections by rinsing with PBS and washed for 10 min with 
two changes of PBS. Sections were overlaid with 50-100,u1 of 
medium, monoclonal antibody 10-3.6.2 against I_Ak (isotope con-
trol), or hybridoma cell culture supernatant containing monoclonal 
antibodies MK.D6 and 14-4-4S and incubated for 60 min in a hu-
midified chamber at room temperature. Sections were washed 2 
times with PBS and incubated for 1 h with overlaid fluorescein-
conjugated goat antimouse IgG (Cappel Biomedical, Inc., Malvern, 
P A). After 2 washings with PBS, sections were covered with a 
glycerol-coated cover glass. Sections were examined with a Leitz 
fluorescent microscope (Leitz Dialux 20, Boyle Instruments, Gig 
Harbor, Washington) and representative photographs made (X250 
magnification) . 
Statistical Analysis The Student's t-test was used to determine 
statistically significant differences in tbe density of ATPase and 
la-positive DEC between the various treatment groups. 
RESULTS 
Gamma-Interferon-Induced Keratinocyte Expression of Ia 
In Vivo The following experiments were conducted to determine 
whether lFN -gamma could induce la expression by keratinocytes in 
vivo. Groups of mice were injected with IFN-gamma by one of the 
four protocols described in the Materials and Methods. The results in 
Table 1 compare the effects of low dose IFN-gamma administered 
either as multiple i.v. injections of increasing doses (103 -105 U /d) 
on 3 consecutive days, as described by Momburg et al [10], or as a 
single s.c. injection into the right ear pinna. Neither treatment 
induced keratinocyte expression of la; however, the intestinal mu-
cosal cells of animals injected intravenously with the three consecu-
tive increasing doses ofIFN-gamma were induced to express Ia (Fig 
1), which is consistent with the results reported previously by 
Momburg et al [10]. The result of this experiment demonstrates that 
the same low dose IFN-gamma treatment that induces Ia expression 
by intestinal mucosal epithelium does not induce la expression by 
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Table 1. Ia Expression by Keratinocytes and Intestinal Mucosal Cells in Mice Treated with Low-Dose IFN-gamma 
ATPase+ Mice with Ia+ Mice with Ia+ 
Treatment> DEO la+ DEC' Kerati nocytesd Mucosal Cells' 
PBS (i.v.) 946 ± 26 886 ± 31 0/6 0/6 
IFN-gamma (i .v.) 1059 ± 72 1026 ± 36 f 1/68 6/6 
PBS (s.c.) 1058 ± 36 1021 ± 29 0/6 . 0/6 
IFN-gamma (s.c.) 1076 ± 31 1123±S8 0/6 0/6 
• BALB/c mice were treated by one of two methods with low-dose lPN-gamma. Animals treated by the first method (i.v.) received i.v. injections oflFN-gamma on 3 consecutive d 
(day 1,103 U/IOO JJI PBS; day 2,10' U/IOO JJI PBS; day 3,10' U/IOO JJI PBS), or PBS (100 JJI/day X 3) as a control. Animals treated by the second method (s.c.) receivedasingle 
s.c. injection of IFN-gamma (10' U/50,u1 PBS) or PBS (50,u1) in the righr ear pinna. Each group consisted of 6 mice. 
b The number of ATPase-expressing DEC/mm" of epidermis is presented as the mean ± SEM calculated from counting 10 fields of 0.1 mm" grids for each biopsy sample. 
, The number of la-expressing DEC/mm" of epidermis is presenred as the mean ± SEM calculated from counting 10 fields of 0.1 mm" grids for each biopsy sample. 
d Data are expressed as the number of animals wbere Ia+ keratinocytes were observed in the epidermis/total number of :lIlimals in tbe particular treatment group. 
• Data are expressed as the number of animals where Ia+ mucosal cells were observed in the epithelium of the small intestine/total number of animals in the particular treatment 
group. 
(The density of la+ DEC in the IFN-gamma group was significantly different from that of the control group, p < 0.05. 
• A focal pattern (see Fig 2) of la+ keratinocyte staining was observed in the epidermal sheets from 1 of the 6 animals in this group. 
keratinocytes. The only effect ofIFN-gamma treatment observed in 
the epidermis of these animals was a slight increase in the density of 
ATPase and la+ DEC. 
Gaspari and Katz [16] recently reported that high doses of IFN-
gamma were effective at inducing keratinocyte la expression in 
vivo. An experiment was conducted in which groups of mice were 
given either a high dose (5 X 105 U /day) or an intermediate dose 
(5 X 10~ U/day} oflFN-gammainjected ipon6consecutived. The 
results of this experiment are presented in Table II. As reported by 
Gaspari and Katz [16], the keratinocytes of mice treated with high-
dose IFN-gamma were induced to express lao Similarly, the keratin-
ocytes of mice injected with an intermediate dose of IFN-gamma 
were induced to express la, although to a lesser extent. A compari-
son of the staining patterns (Fig 2) revealed that high-dose IFN-
gamma treatments induced diffuse Ia expression by the keratino-
cytes, whereas the intermediate dose resulted in focal keratinocyte 
Figure 1. Ia expression by cells within the small intestine. Frozen sections of small intestine were stained by indirect immunofluorescence to detect Ia+ cells. 
Primary antibodies MK.D6 and 14-4-4S were used to identify cells expressing I-A and I-E antigens. respectively. A fluorescein-conjugated goat anti-mouse 
IgG (1 :20 dilution) was used to detect primary antibody binding. Ia+ cells were identified in the lamina propria (LP) of the intestinal villi of mice treated with 
PBS (A). la-expressing cells were not observed in either viIIi (V) or crypts (C) of the intestine of animals treated with PBS. In comparison. mucosal cells within 
the intestinal villi (V) (arrows) and crypts (C) (*) were induced to express Ia in IFN-garnma-treated animals (B) . The staining patterns depicted in these 
photomicrographs (X2S0) are rypical of those observed in all the experiments presented in this study. Fluorescent-labeled cells were not observed in frozen 
sections stained with either monoclonal antibody 10-3.6.2 (inappropriate haplotype, Iak) and fluorescent second antibody or the second antibody alone (not 
shown). 
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Table II. Keratinocyte Expression of Ia in Mice Injected With Intermediate and High Doses of IFN-gamma 
Pattern of Ia Expression· 
Mice with Ia+ Mice with la+ 
Treatment" Keratinocytesb Focal Diffuse Intestinal Epitheliumd 
PBS 0/6 0 0 0/6 
Intermediate dose 4/5 4 0 5/5 
High dose 5/5 0 5 5/5 
• BAlB/c mice were injected with an intermediate dose oflFN-gamma (5 X 10' U/day administered intraperitoneally on 6 consecutive d), a high dose oflFN-gamma (5 X 10' 
U/ day adminisrered intraperitoneally on 6 consecutive d), or PBS (100 ,uI/day intraperitoneally on 6 consecutive d) as a control. 
b Number of animals with 1>+ keratinocytes/total number of animals in the particular treatment group. 
, Focal and diffuse patterns ofla+ keratinocyte staining are depicted in Figure 2 photomicrographs. Data:Lte presented as the number of animals with la+ keratinocytes that displayed 
a p:Ltticul:Lt staining pattern. 
d Data :Lte expressed as the number of animals where la+ mucosal cells were observed in the epithelium of the small intestine/total number of animals in the particular treatment 
group. 
expression ofIa. Expression ofIa antigens on the surface ofkeratino-
cytes from an epidermal sheet displaying a diffuse pattern of expres-
sion is best demonstrated under a higher power of magnification 
(Fig 3). Both treatment doses caused Ia expression by intestinal 
mucosal epithelium (Table II). 
Elfects ofGanuna-Interferon and Combined Treatments on 
Keratinocyte Ia Expression We have found that keratinocytes 
of athymic nude mice are readily induced to express Ia in response to 
a variety of stimuli (e.g., i.v. injection of normal sera, IFN treat-
ments, and topical application of contact sensitizing agents) [17]. 
This suggests that multiple signals may trigger keratinocyte la ex-
pression. It was recently reported that the pancreatic islet cells of 
experimentally induced diabetic mice express high levels ofIa when 
treated with a combination of streptozotocin and IFN-gamma [18]. 
In this model system, lFN-gamma treatments alone (2 X 104 U / 
day given intraperitoneally on 5 consecutive d) failed to induce 
detectable fa expression by the islet cells [18]. These results add 
Figure 2. la expression by epidermal cells. An indirect immunoperoxidase method was employed to identify Ia+ cells in the epidermis. Epidermal sheets were 
stained with monoclonal antibodies MK.D6 (specific for I_Ad) and 14-4-45 (specific for the Ia7 determinant expressed on I-E antigens). Epidermal sheets 
incubated with the irrelevant, isotope antibody control (monoclonal antibody 10-3.6.2) showed no detectable background staining by this method (A). Hair 
follicles (hf) are often recognized by this staining procedure. Langerhans cells (arrows) ace the only la-expressing cells observed in epidermal sheets obtained 
from normal mice (B) . Keratinocyte expression of Ia is described as either focal or diffuse. Focal staining (C) refers to a pattern where patches of Ia+ 
keratinocytes (enclosed area) were observed over at least 30% of the epidermis. Langerhans cells can easily be identified in these epidermal sheets (arrows). 
Diffuse staillin~ (D) refers to a pattern where the keratinocytes throughout the entire epidermal sheet were induced to express Ia. The enclosed area around the 
hair follicle (h}) is shown at higher power in Figure 3. The staining patterns depicted in these photomicrographs (X250) are typical of those observed in all the 
experiments that are presented in this study. 
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Figure 3. Cell surface expression ofla antigens by keratinocytes. The pho-
tomicrograph is a higher power (X400) view of the enclosed area around the 
hair follicle (hf) shown in Figure 2D. The Ia antigens are found to be 
expressed on the cell surface of the keratinocytes (arrows) at this magnifica-
tion. The keratinocytes were stajned by the indirect immunoperoxidase 
method (described in the Materials and Methods) using monoclonal antibodies 
MK.D6 and 14-4-4S to identify Ia antigens. 
support to the argument that multiple stimuli, one of which may be 
provided by IFN-gamma, are required to induce certain cell types to 
express class II antigens. The following experiments were thus con-
ducted to determine whether IFN-gamma (administered at low 
doses) in combination with a second stimulus would induce keratin-
ocyte Ia expression. In all experiments described in Tables III - VI, 
keratinocytes were not induced to express la in control groups that 
were injected with PBS or low dose IFN-gamma alone, although 
la-expressing mucosal cells were always observed in the IFN-
gamma treatment groups. Equal numbers of mice were included in 
the control and experimental groups for these experiments. 
Pertussis toxin has a potent adjuvantlike effect on contact hyper-
sensitivity responses [19] . Increased magnitude and duration of con-
tact hypersensitivity reactions are associated with diminished im-
munoregulatory activities in PT-treated mice [20,21]. In addition, 
the enhanced contact hypersensitivity observed in PT-treated mice 
is paralleled by the intense expression ofIa by the keratinocytes [22]. 
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Table IV. la Expression by Keratinocytes in Mice Treated with 
Low-Dose IFN-garnma and Indomethacin 
Treatment' 
Indomethacin pellet 
Indomethacin pellet 
None 
Indomethacin pellet 
PBS 
IFN-gamma (i.v.) 
IFN-gamma (i.p.) 
IFN-gamma (i.p.) 
Mjce with Ia+ 
Keratinocytesb 
0/6 
0/6 
4/6 (focal)' 
5/6 (1 dilfuse)d 
• BAU3/c mice received a subcutaneous implant of an indomethacin-containing 
pellet and 5 d later were given either low-dose IFN-gamma treatments (i.v. administra-
rion of 10' u. 10' U. and 10' U/loo J.d PBS given on 3 consecutive d. respectively). 
equal volumes of PBS as a control. Or an intennediate IFN-g2.ll1Jtla i.p. dose (5 X IO-
U /day on 6 consecutive d). 
b Data are expressed as rhe numbcr of animals in which Ia+ keratinocytes were 
observed in the epidermis/total number of animals in the particular treatment group. 
e A focal pattern ofla expression by the keratinocytes (see Fig 2) was observed in 4 of 6 
animals. 
d A focal pattern oHa expression by the keratinocytes (see Fig 2) was observed in 4 of 
5 positive an.imals. whereas diffuse Ia expression was displayed by the remaining posi-
tive animal in this group. 
The PT has also been shown to augment antigen-driven IFN pro-
duction by sensitized lymphoid cells [23]. Considering these corre-
lative effects, the following experiment was performed to deter-
mine whether PT could enhance the ability of IFN-garnma to 
induce la expression by keratinocytes. The results of this experi-
ment (Table Ill) showed that low-dose IFN-gamma in combination 
with PT treatment did not induce la expression by keratinocytes. 
although Ia expression by intestinal mucosal epithelium was ob-
served. In this experiment, an increase in ATPase and Ia+ DEC 
density was associated with the various IFN-gamma and PT treat-
ments. 
Piacibello et al [24] have reported that prostaglandins counteract 
the ability of fFN-gamma to induce increased expression of fa by 
macrophages. Because keratinocytes produce prostaglandins 
[25,26 J, an experiment was conducted to determine whether prosta-
glandins had an inhibitory effect on the ability of IFN-gamma to 
induce la expression by keratinocytes. Groups of mice were given 
either a low dose of IFN-gamma intravenously or an intermediate 
dose oflFN-gamma intraperitoneally in an attempt to induce kera-
tinocyte la expression. Animals in one of each of the treatment 
groups received a subcutaneous implant of an indomethacin pellet 
before the IFN-gamma treatment to inhibit prostaglandin synthesis 
[11]. Low-dose IFN-gamma did not cause keratinocyte expression 
of Ia when given to mice treated with indomethacin. Likewise, 
indomethacin treatment did not have any marked influence on the 
qual itative expression ofIa by the keratinocytes of mice treated with 
intermediate doses of IFN-gamma. The results of this experiment 
show that the combination ofIFN-garnma and indomethacin does 
not augment the inducible Ia expression by keratinocytes to any 
significant degree. 
It has been shown that the intensity and duration of contact 
Table m. la Expression by Keratinocytes and Intestinal Mucosal Cells in Mice Treated with Low-Dose IFN-gamma and Pertussis Toxin 
Treatment' 
ATPase+ Mice with Ia+ Mice with Ia+ 
Day 0 Days 1-3 DEO Ia+ DEC' Keratinocytesd Mucosal Cells' 
PT PBS 1050 ± 31 1011 ±52 0/3 3/3 
PT IFN-gamma 1263 ± 41f 1215 ± 48( 0/3 3/3 
• BALB/c mice were pretreated with pertussis toxin (200 ng/loopl PBS) administered intravenously 1 d before freacment with IFN-gamma. The animals were given either 
low-dose IFN-gamma treatments (i.v. administration of 10' U. 10' U. and 10' U/loo pi PBS given on 3 consecutive d, respecrively) or equal volumes of PBS as a control. 
b The number of ATPase-expressing DEC/mm' of epidermis is presented as the mean ± SEM calculated from counting 10 fields of 0.1 nun' grids for each biopsy sample. 
r The number of la-expressing DEC/mm' of epidermis is presented as the mean ± SEM calculated from counting 10 fields of 0.1 mm' grids for each biopsy sample. 
d D.t. are expressed as the number of animals in which la+ keratinocytes were observed in the epidermis/total number of an.imals in the particular treatment group . 
• Data are expressed as the number of animals in which 12+ mucosal cel ls were observed in the epithelium of the snull intestine/rotal number of animals in the particular treatment 
group. 
'The density of ATPase/la+ DEC in the IFN-gamma group was significantly different from the r<spective PBS control. p < 0.05. 
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Table V. la EXlression by Keratinocytes in DNFB-Sensitized 
and Challenge Mice Treated with Low-Dose lFN-gamma 
Treatment> 
Amount of Mice with Ia+ 
Day 0 Days 4-6 Day 9 Ear Swellingb Keratinocytes< 
DNFB PBS None 3.0 ± 0.8 0/3 
None IFN-gamma None 1.3 ± 1.2 0/3 
DNFB IFN-gamma None 4.0 ± 1.4 0/3 
None PBS ONFB 6.0 ± 4.3 0/3 
None IFN-gamma None 0.3 ± 0.4 0/3 
None IFN-gamma DNFB 4.7 ± 3.8 0/3 
• BALB/c mice received a topical application to the right eu pinna of 10 ill of 0.5% 
DNFB solu~on e~ther 3 d before or after treatment with low-dose IFN-gamma. Aru-
rnals were given either low-dose IFN-gamma treatments (i.v. administration of 10' U, 
10' U, and 10' U/l00 ill PBS given on 3 consecutive d, respectively), or equal volumes 
of PBS a.s • control. 
• Ear swelling was mea.sured 24 h after the last treatment. Data ue reported as 
mean ± SEM (10- ' inch) units of ear swelling for each group. 
e Data are expressed a.s the number of animals in which Ia+ keratinocytes were 
observed in the epidermis/total number of animals in the particulu treatment group. 
hypersensitivity reactions in mice is associated with the level of la 
expressed by keratinocytes [22] , This suggests that la+ keratinocytes 
are involved in facilitating the movement or sequestration of 
lymphoid cells in the skin in response to antigenic stimulation with 
a contact sensitizing agent, The following experiment was per-
formed to determine whether antigenic stimulation in combination 
with IFN-gamma would affect keratinocyte expression of Ia. 
Groups of mice were injected with low dose IFN-gamma either 
before or after th~ topica~ application of DNFB to the ear pinna. 
The results of thIS expenment (Table V) showed that combined 
DNF.B and IFN-gamma treatment did.not induce la expression by 
keratmocytes. Furthermore, ear swellmg responses to the single 
topical appli~at~on of DNFB were no~ enhan~ed by IFN-gamma 
treatment. Surular to the results obtamed WIth combined indo-
methacin and intermediate doses of IFN-gamma, DNFB did not 
augment the effect of an intraperitoneally administered interme-
diate dose of lFN-gamma (data not presented). 
It has .been. reported that TNF, through either a direct or indirect 
mechamsm, mfluences MHC gene expression by nontransformed 
cells [27,28]. The TNF also has a synergistic effect with IFN-
gamma for both ac~ivating neutrophils [29] and inducing increased 
levels of la expressIOn by monocytes [30]. An experiment was thus 
conducted to determine whe.ther combined l~w-dose IFN-gamma 
and TNF treatme.nts wo~ld mduce la expressIon by keratinocytes. 
The results of thIS expenment showed that even in combination 
with TNF, low-dose IFN-gamma treatments fail to induce keratin-
ocyte Ia expression (Table VI) . Interestingly, the intestinal mucosal 
epithelium was induced to express la whether the lFN-gamma and 
TNF were administered in combination or separately. From these 
e.xperimen~s w~ conc~ude t~at murine keratinocytes are less respon-
sIve to the m VIVO la-mducmg properties of IFN-gamma compared 
Table VI. Ia Expression by Keratinocytes and Intestinal 
Mucosal Cells in Mice Treated with Low-Dose IFN-gamma and 
Tumor Necrosis Factor 
Treatment' 
PBS 
IFN-gamma 
TNF 
IFN-gamrna + TNF 
Mice with la+ 
Keratinocytesb 
0/6 
0/6 
0/6 
0/6 
Mice with Ia+ 
Mucosal Cells' 
0/6 
6/6 
6/6 
6/6 
• BALB/c mice received either low-dose IFN-gamma (i.v. administration of 10' U, 
10' U, and 10' U/I00 ill PBS given on 3 consecutive d, respectively), or a combination 
of low-dose IFN-gamrna and TNF. 
b Data are expressed as the number of .nirnals in which la+ keratinocytes were 
observed in the epidermis/total number of .nimals in the particulu treatment group. 
e Data are expressed a.s the number of animals in which b+ mucosal cells were 
observed in the epithelium of the small intestine/total numberoC animals in the p:uticu-
lac treatment group. 
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with other epithelial cell populations [10], and the regulation of 
keratinocyte la expression in normal mice is resistant to the effects 
of low-dose IFN-gamma, even when given in combination with 
other stimuli. 
DISCUSSION 
It has been shown that IFN-gamma enhances the synthesis and 
surface expression of class I and class II antigens in a variety of cell 
types [31 - 35]. Although human keratinocytes are readily induced 
to express HLA-DR antigens when cultured in vitro with recombi-
nant human IFN-gamma [6], similar results have not been obtained 
in murine systems. We have found that when PAM 212 cells (a 
murine squamous cell carcinoma) are cultured with recombinant 
murine IFN-gamma, less than 10% of the cells are induced to ex-
press low amounts of la on their surface. Although not induced to 
express la, we found that PAM 212 cells were responsive to IFN-
gamma, as these cells were induced to express increased amounts of 
class I antigen when incubated with IFN-gamma (unpublished ob-
servations). This suggests that murine keratinocytes are less respon-
sive to the la-inducing properties ofIFN-gamma. Our current study 
shows that the induced expression of Ia by keratinocytes is both 
IFN-gamma dose-dependent and distinct from intestinal mucosal 
cells. This indicates that murine keratinocytes, in comparison to 
other cell types [10], are less responsive to the la-inducing effects of 
IFN-gamma. The mechanisms that distinguish human and murine 
keratinocytes regarding their IFN-gamma-induced expression of 
class II antigens await further investigation. 
Much of the interest in this area has come from the observations 
in which class II antigen expression by keratinocytes is associated 
with certain skin diseases and conditions [1 - 4]. Because most of 
these disorders are marked by inflammatory and immune cell infil-
trates in the skin, it is thought that activated T -cells, which localize 
in the skin, may release high enough concentrations ofIFN-gamma 
to induce class II antigen expression by the keratinocytes. Although 
Ia/HLA-DR expression by keratinocytes may represent a marker of 
certain immune reactions or diseases in the skin with little or no 
biologic consequence, several lines of evidence indicate that these 
cells have some functio~al role. First, the expression of class II 
molecules by nonlymphOld cells, such as endothelial and epithelial 
~ells, max represent the means by which these cells gain tissue-local-
Ized antigen-presenting capabilities. In this regard, HLA-DR-ex-
pressing endothelial cells are known to function as effective anti-
gen-l?resenting cells [35,36]. In contrast, Ia/HLA-DR-expressing 
~erattn?cxtes appear to be more restricted in their antigen-present-
mg activIty [37,38]. Second, we have reported that keratinocyte 
expression of Ia is correlated with the movement of Ia+ DEC into 
the epidermis [9], as well as the duration and intensity of contact 
hype~sensitivity r~actions [22]. Third, la+ keratinocytes gain the 
capacity. to function as attractants for the migration of certain 
Iympho!d ~ell~ [39]. Fourth, experiments conducted with athymic 
nude rmce mdlcate that keratinocyte expression of la is both regu-
lated [40] ~d inducible by stimuli that are independent ofT-lym-
phocytes (I.e. , do not require IFN-gamma) [9,22]. Fifth, keratino-
cytes synthesize and secrete a number of soluble immune mediators, 
e.g., interleuic0-1 [~l], interleukin-3 [42,43], granulocyte/mono-
cyte colony.-mmulattng factor [42], and prostaglandins [25,26] . Be-
cause k~ratmocytes possess many of the characteristics of antigen-
presenttng cells (e.g., regulated expression of class II molecules and 
synthesis of soluble immune mediators), further knowledge of their 
potential immunologic role in skin-associated immune reactions 
will increase our understanding of the mechanisms involved in var-
ious skin di.sease proc.esses and may allow for the development of 
more effective therapies for these disorders . 
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